Bio Pharma Dive
NOVEMBER 21, 2024
The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a treatment that can improve upon drugs like Wegovy and Zepbound.
Rethinking Clinical Trials
NOVEMBER 21, 2024
In a new commentary, members of the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core explore the potential of pragmatic trials to improve demographic representativeness and health equity in clinical research. The article, “Untapped Potential? Representativeness in Pragmatic Clinical Trials,” was published online ahead of print in JAMA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 21, 2024
Critical infrastructure in biopharma and medical devices plays a vital role in enabling innovation, bolstering research and development, and ensuring the production of novel drugs and products. It ensures scalability, quality control, and regulatory compliance.
Bio Pharma Dive
NOVEMBER 21, 2024
Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to overcome the looming loss of exclusivity for some of its top-selling medicines.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
XTalks
NOVEMBER 21, 2024
Eli Lilly shared new data last week from a study, which highlights the long-term efficacy of tirzepatide in preventing diabetes progression among prediabetic patients. Results from the Phase III SURMOUNT-1 three-year study (176-week treatment period) showed that nearly 99 percent of participants remained diabetes-free over three years. SURMOUNT is the longest completed study to date of tirzepatide.
Bio Pharma Dive
NOVEMBER 21, 2024
Venture capital firms incubate, grow and finance dozens of new drug companies each year. Follow the money they channel into the industry with this database.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
NOVEMBER 21, 2024
Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML
XTalks
NOVEMBER 21, 2024
The US Food and Drug Administration (FDA) has granted Breakthrough Device clearance to Ultromics’ EchoGo Amyloidosis device through its Total Product Lifecycle Advisory Program (TAP). Cardiac amyloidosis, a serious and often underdiagnosed heart condition, poses significant diagnostic challenges even for experienced clinicians. It is characterized by the build-up of abnormal protein deposits in the heart tissue, leading to stiffening of the heart walls and impairing its ability to pump blood eff
Bio Pharma Dive
NOVEMBER 21, 2024
In buying Westlake-backed Kate Therapeutics, Novartis gets a handful of preclinical gene therapies targeting diseases like Duchenne muscular dystrophy and myotonic dystrophy type 1.
Pharmaceutical Technology
NOVEMBER 21, 2024
Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
NOVEMBER 21, 2024
The biotech will use the funding to drive sales of its first commercial product
Pharmaceutical Technology
NOVEMBER 21, 2024
Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in importance.
pharmaphorum
NOVEMBER 21, 2024
Explore how investing in genomic medicine can unlock the true business potential in the manufacturing and therapeutic areas. Understand the promise and reality of this cutting-edge field.
Pharmaceutical Technology
NOVEMBER 21, 2024
RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.
pharmaphorum
NOVEMBER 21, 2024
Novartis buys gene therapy specialist Kate Therapeutics for $1.
Pharmaceutical Technology
NOVEMBER 21, 2024
The South Korean CDMO has now partnered with 17 of the world’s top 20 pharma companies, as per the company.
pharmaphorum
NOVEMBER 21, 2024
Discover how Within3's community-driven platform helps businesses gather and utilise data effectively. Explore our solution spotlight for insights into their innovative approach.
Pharmaceutical Technology
NOVEMBER 21, 2024
The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell platforms.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
NOVEMBER 21, 2024
Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug.
Pharmaceutical Technology
NOVEMBER 21, 2024
The EC has granted marketing authorisation for Pfizer's anti-tissue factor pathway inhibitor (anti-TFPI), HYMPAVZI to treat haemophilia.
pharmaphorum
NOVEMBER 21, 2024
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
BioPharma Reporter
NOVEMBER 21, 2024
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.
pharmaphorum
NOVEMBER 21, 2024
Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes.
Medical Xpress
NOVEMBER 21, 2024
A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach that paves the way for more personalized treatment strategies for patients with this deadly brain tumor.
Fierce Pharma
NOVEMBER 21, 2024
Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of Roche's Vabysmo on Asian patients with polypoidal choroidal vasculopathy suggest that the injected treatment is effective. After 16 weeks, patients showed vision improvement which was equivalent to reading roughly one and a half more lines on an eye chart.
Medical Xpress
NOVEMBER 21, 2024
Life expectancy in the U.S. varies by more than 20 years depending on an individual's race and ethnicity and where they live. These widespread and persistent life expectancy disparities have divided the country into "ten Americas," according to new research examining inequities in US life expectancy between 2000 and 2021, published in The Lancet.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
NOVEMBER 21, 2024
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.
Medical Xpress
NOVEMBER 21, 2024
New research by a team at Georgia State University is uncovering surprising insights about brain pathways that could offer alternative ways for practitioners to identify early signs of schizophrenia. The research is published in the journal Nature Mental Health.
My Local Study
NOVEMBER 21, 2024
The rise of decentralized clinical trials (DCTs) has redefined how research is conducted, making patient recruitment a critical component of trial success. Efficient recruitment strategies ensure that research sites, sponsors, and CROs can identify and engage the right participants. Streamlined tools and processes are essential for achieving these goals, fostering greater engagement while addressing logistical.
pharmaphorum
NOVEMBER 21, 2024
Pfizer has named chief oncology officer Dr Chris Boshoff to the new role of chief of R&D
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
310 
Let's personalize your content